November 6, 2018 / 1:41 PM / in 13 days

BUZZ-Bausch Health: Gains on third-quarter revenue beat

** Drugmaker’s shares rise 4 pct to $26.6 in premarket trading

** Co reported revenue of $2.14 bln for Q3, while analysts were expecting $2.08 bln, as per Refinitiv data

** BHC beat revenue estimates for the third consecutive quarter

** Co expects ongoing steps to improve working capital by reducing U.S. channel inventory in Q4 to affect quarterly revenue and profit; raises FY 2018 adj. EBITDA guidance to $3.3 bln-$3.45 bln from $3.20 bln–$3.35 bln

** Up to Monday’s close, BHC climbed 23 pct YTD (Reporting by Manogna Maddipatla)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below